SCHEMBL2467657

SCHEMBL2467657

Cc1cc(Oc2ccccc2)cc(C)c1CC=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.41
TSHR P16473 1/20 0.41
MAPK14 Q16539 1/20 0.39
SRD5A2 P31213 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TTR P02766 1/20 0.37
KMT2A Q03164 2/20 0.37
GSTP1 P09211 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
HPGD P15428 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
NLRP3 Q96P20 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14992587 0.98 LTA4H (0.42) LTA4HTSHRMAPK14SRD5A2HTT
SCHEMBL2464188 0.85 LTA4H (0.41) LTA4HTSHRHTTSMN1; SMN2KMT2A
SCHEMBL2466303 0.84 SMN1; SMN2 (0.45) SMN1; SMN2LMNAPOLB
SCHEMBL2468010 0.83 CYP1A2 (0.40) LTA4HMAPK14HPGDL3MBTL1
SCHEMBL27986865 0.83 LTA4H (0.39) LTA4HTSHRSRD5A2HTTSMN1; SMN2
SCHEMBL2464179 0.82 SMN1; SMN2 (0.40) MAPK14SRD5A2HTTSMN1; SMN2LMNA
SCHEMBL14992485 0.81 ALDH1A3 (0.45) KMT2ALMNAGAANPC1RAB9A
SCHEMBL2464598 0.80 MAPK14 (0.42) LTA4HMAPK14KMT2ALMNAL3MBTL1
SCHEMBL14992341 0.79 KDM4E (0.38) LTA4HHPGD
SCHEMBL14993376 0.77 LTA4H (0.37) LTA4HTSHRSMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2785714-A1 IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR Taivex Therapeutics Corporation (TW) 2014-10-08 EP disclosed
WO-2013082324-A1 IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR TAIVEX THERAPEUTICS CORPORATION (TW) 2013-06-06 WO disclosed
EP-2547676-A2 MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR Taivex Therapeutics Inc. (TW) 2013-01-23 EP disclosed
WO-2011115998-A2 MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR TAIVEX THERAPEUTICS INC. (CN) 2011-09-22 WO disclosed